nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemfibrozil—SLCO1B1—Methotrexate—urinary bladder cancer	0.079	0.17	CbGbCtD
Gemfibrozil—CYP3A4—Thiotepa—urinary bladder cancer	0.0757	0.163	CbGbCtD
Gemfibrozil—CYP2C8—Fluorouracil—urinary bladder cancer	0.0607	0.13	CbGbCtD
Gemfibrozil—CYP2C8—Etoposide—urinary bladder cancer	0.0506	0.109	CbGbCtD
Gemfibrozil—CYP1A2—Fluorouracil—urinary bladder cancer	0.047	0.101	CbGbCtD
Gemfibrozil—CYP2C9—Fluorouracil—urinary bladder cancer	0.0423	0.091	CbGbCtD
Gemfibrozil—CYP1A2—Etoposide—urinary bladder cancer	0.0392	0.0843	CbGbCtD
Gemfibrozil—CYP2C9—Cisplatin—urinary bladder cancer	0.0359	0.0773	CbGbCtD
Gemfibrozil—CYP3A4—Etoposide—urinary bladder cancer	0.0205	0.0442	CbGbCtD
Gemfibrozil—CYP3A4—Doxorubicin—urinary bladder cancer	0.014	0.0301	CbGbCtD
Gemfibrozil—CYP2C19—urine—urinary bladder cancer	0.0085	0.116	CbGeAlD
Gemfibrozil—PPARA—prostate gland—urinary bladder cancer	0.00734	0.1	CbGeAlD
Gemfibrozil—CYP1A2—urine—urinary bladder cancer	0.00694	0.0946	CbGeAlD
Gemfibrozil—CYP2C9—urine—urinary bladder cancer	0.00659	0.0898	CbGeAlD
Gemfibrozil—PPARA—epithelium—urinary bladder cancer	0.0054	0.0735	CbGeAlD
Gemfibrozil—PPARA—smooth muscle tissue—urinary bladder cancer	0.0052	0.0708	CbGeAlD
Gemfibrozil—CYP3A4—urine—urinary bladder cancer	0.00502	0.0684	CbGeAlD
Gemfibrozil—PPARA—renal system—urinary bladder cancer	0.00501	0.0682	CbGeAlD
Gemfibrozil—PPARA—female reproductive system—urinary bladder cancer	0.00401	0.0546	CbGeAlD
Gemfibrozil—SLCO1B1—renal system—urinary bladder cancer	0.00319	0.0435	CbGeAlD
Gemfibrozil—SLCO1B1—female reproductive system—urinary bladder cancer	0.00256	0.0348	CbGeAlD
Gemfibrozil—PPARA—lymph node—urinary bladder cancer	0.00235	0.032	CbGeAlD
Gemfibrozil—CYP2C8—renal system—urinary bladder cancer	0.00181	0.0247	CbGeAlD
Gemfibrozil—CYP1A2—renal system—urinary bladder cancer	0.0017	0.0231	CbGeAlD
Gemfibrozil—CYP2C19—vagina—urinary bladder cancer	0.00151	0.0205	CbGeAlD
Gemfibrozil—CYP2C8—female reproductive system—urinary bladder cancer	0.00145	0.0198	CbGeAlD
Gemfibrozil—CYP2C8—vagina—urinary bladder cancer	0.00131	0.0179	CbGeAlD
Gemfibrozil—CYP2C9—female reproductive system—urinary bladder cancer	0.00129	0.0176	CbGeAlD
Gemfibrozil—CYP3A4—renal system—urinary bladder cancer	0.00123	0.0167	CbGeAlD
Gemfibrozil—CYP3A4—female reproductive system—urinary bladder cancer	0.000984	0.0134	CbGeAlD
Gemfibrozil—Somnolence—Gemcitabine—urinary bladder cancer	0.000447	0.00163	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.000445	0.00162	CcSEcCtD
Gemfibrozil—Paraesthesia—Fluorouracil—urinary bladder cancer	0.000444	0.00162	CcSEcCtD
Gemfibrozil—Pancreatitis—Methotrexate—urinary bladder cancer	0.000444	0.00162	CcSEcCtD
Gemfibrozil—Breast disorder—Epirubicin—urinary bladder cancer	0.000443	0.00162	CcSEcCtD
Gemfibrozil—Somnolence—Fluorouracil—urinary bladder cancer	0.00044	0.00161	CcSEcCtD
Gemfibrozil—Nasopharyngitis—Epirubicin—urinary bladder cancer	0.000438	0.0016	CcSEcCtD
Gemfibrozil—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000436	0.00159	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000435	0.00159	CcSEcCtD
Gemfibrozil—Fatigue—Gemcitabine—urinary bladder cancer	0.000434	0.00158	CcSEcCtD
Gemfibrozil—Confusional state—Etoposide—urinary bladder cancer	0.000433	0.00158	CcSEcCtD
Gemfibrozil—Muscular weakness—Epirubicin—urinary bladder cancer	0.000432	0.00158	CcSEcCtD
Gemfibrozil—Pain—Gemcitabine—urinary bladder cancer	0.00043	0.00157	CcSEcCtD
Gemfibrozil—Constipation—Gemcitabine—urinary bladder cancer	0.00043	0.00157	CcSEcCtD
Gemfibrozil—Pancytopenia—Methotrexate—urinary bladder cancer	0.00043	0.00157	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Etoposide—urinary bladder cancer	0.00043	0.00157	CcSEcCtD
Gemfibrozil—Asthenia—Thiotepa—urinary bladder cancer	0.000429	0.00157	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000427	0.00156	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000427	0.00156	CcSEcCtD
Gemfibrozil—Pruritus—Thiotepa—urinary bladder cancer	0.000423	0.00154	CcSEcCtD
Gemfibrozil—Pain—Fluorouracil—urinary bladder cancer	0.000423	0.00154	CcSEcCtD
Gemfibrozil—Paraesthesia—Cisplatin—urinary bladder cancer	0.000421	0.00154	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Etoposide—urinary bladder cancer	0.000421	0.00154	CcSEcCtD
Gemfibrozil—Eosinophilia—Epirubicin—urinary bladder cancer	0.000419	0.00153	CcSEcCtD
Gemfibrozil—Liver function test abnormal—Doxorubicin—urinary bladder cancer	0.000419	0.00153	CcSEcCtD
Gemfibrozil—Skin disorder—Etoposide—urinary bladder cancer	0.000417	0.00152	CcSEcCtD
Gemfibrozil—Erectile dysfunction—Methotrexate—urinary bladder cancer	0.000417	0.00152	CcSEcCtD
Gemfibrozil—Pancreatitis—Epirubicin—urinary bladder cancer	0.000415	0.00152	CcSEcCtD
Gemfibrozil—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000415	0.00151	CcSEcCtD
Gemfibrozil—Abdominal pain upper—Doxorubicin—urinary bladder cancer	0.000414	0.00151	CcSEcCtD
Gemfibrozil—Photosensitivity reaction—Methotrexate—urinary bladder cancer	0.000413	0.00151	CcSEcCtD
Gemfibrozil—Breast disorder—Doxorubicin—urinary bladder cancer	0.00041	0.0015	CcSEcCtD
Gemfibrozil—Diarrhoea—Thiotepa—urinary bladder cancer	0.000409	0.00149	CcSEcCtD
Gemfibrozil—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000408	0.00149	CcSEcCtD
Gemfibrozil—Nasopharyngitis—Doxorubicin—urinary bladder cancer	0.000406	0.00148	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000405	0.00148	CcSEcCtD
Gemfibrozil—Depression—Methotrexate—urinary bladder cancer	0.000403	0.00147	CcSEcCtD
Gemfibrozil—Pancytopenia—Epirubicin—urinary bladder cancer	0.000402	0.00147	CcSEcCtD
Gemfibrozil—Pain—Cisplatin—urinary bladder cancer	0.000401	0.00146	CcSEcCtD
Gemfibrozil—Muscular weakness—Doxorubicin—urinary bladder cancer	0.0004	0.00146	CcSEcCtD
Gemfibrozil—Renal failure—Methotrexate—urinary bladder cancer	0.000397	0.00145	CcSEcCtD
Gemfibrozil—Dizziness—Thiotepa—urinary bladder cancer	0.000396	0.00144	CcSEcCtD
Gemfibrozil—Urticaria—Fluorouracil—urinary bladder cancer	0.000393	0.00143	CcSEcCtD
Gemfibrozil—Eosinophilia—Doxorubicin—urinary bladder cancer	0.000388	0.00142	CcSEcCtD
Gemfibrozil—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.000387	0.00141	CcSEcCtD
Gemfibrozil—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000387	0.00141	CcSEcCtD
Gemfibrozil—Paraesthesia—Etoposide—urinary bladder cancer	0.000386	0.00141	CcSEcCtD
Gemfibrozil—Pancreatitis—Doxorubicin—urinary bladder cancer	0.000384	0.0014	CcSEcCtD
Gemfibrozil—Weight decreased—Epirubicin—urinary bladder cancer	0.000383	0.0014	CcSEcCtD
Gemfibrozil—Somnolence—Etoposide—urinary bladder cancer	0.000382	0.00139	CcSEcCtD
Gemfibrozil—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.000382	0.00139	CcSEcCtD
Gemfibrozil—Vomiting—Thiotepa—urinary bladder cancer	0.00038	0.00139	CcSEcCtD
Gemfibrozil—Rash—Thiotepa—urinary bladder cancer	0.000377	0.00138	CcSEcCtD
Gemfibrozil—Dermatitis—Thiotepa—urinary bladder cancer	0.000377	0.00138	CcSEcCtD
Gemfibrozil—Headache—Thiotepa—urinary bladder cancer	0.000375	0.00137	CcSEcCtD
Gemfibrozil—Pancytopenia—Doxorubicin—urinary bladder cancer	0.000372	0.00136	CcSEcCtD
Gemfibrozil—Renal failure—Epirubicin—urinary bladder cancer	0.000371	0.00135	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000371	0.00135	CcSEcCtD
Gemfibrozil—Fatigue—Etoposide—urinary bladder cancer	0.000371	0.00135	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.00037	0.00135	CcSEcCtD
Gemfibrozil—Jaundice—Epirubicin—urinary bladder cancer	0.000368	0.00134	CcSEcCtD
Gemfibrozil—Constipation—Etoposide—urinary bladder cancer	0.000368	0.00134	CcSEcCtD
Gemfibrozil—Pain—Etoposide—urinary bladder cancer	0.000368	0.00134	CcSEcCtD
Gemfibrozil—Urinary tract infection—Epirubicin—urinary bladder cancer	0.000367	0.00134	CcSEcCtD
Gemfibrozil—Asthenia—Gemcitabine—urinary bladder cancer	0.000361	0.00132	CcSEcCtD
Gemfibrozil—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.000358	0.00131	CcSEcCtD
Gemfibrozil—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000357	0.0013	CcSEcCtD
Gemfibrozil—Pruritus—Gemcitabine—urinary bladder cancer	0.000356	0.0013	CcSEcCtD
Gemfibrozil—Nausea—Thiotepa—urinary bladder cancer	0.000355	0.0013	CcSEcCtD
Gemfibrozil—Weight decreased—Doxorubicin—urinary bladder cancer	0.000355	0.00129	CcSEcCtD
Gemfibrozil—Feeling abnormal—Etoposide—urinary bladder cancer	0.000354	0.00129	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000351	0.00128	CcSEcCtD
Gemfibrozil—Pruritus—Fluorouracil—urinary bladder cancer	0.00035	0.00128	CcSEcCtD
Gemfibrozil—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000344	0.00126	CcSEcCtD
Gemfibrozil—Renal failure—Doxorubicin—urinary bladder cancer	0.000344	0.00125	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.000343	0.00125	CcSEcCtD
Gemfibrozil—Urticaria—Etoposide—urinary bladder cancer	0.000341	0.00125	CcSEcCtD
Gemfibrozil—Jaundice—Doxorubicin—urinary bladder cancer	0.000341	0.00124	CcSEcCtD
Gemfibrozil—Rhinitis—Epirubicin—urinary bladder cancer	0.00034	0.00124	CcSEcCtD
Gemfibrozil—Abdominal pain—Etoposide—urinary bladder cancer	0.00034	0.00124	CcSEcCtD
Gemfibrozil—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.00034	0.00124	CcSEcCtD
Gemfibrozil—Eye disorder—Methotrexate—urinary bladder cancer	0.000339	0.00124	CcSEcCtD
Gemfibrozil—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000339	0.00124	CcSEcCtD
Gemfibrozil—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000337	0.00123	CcSEcCtD
Gemfibrozil—Asthenia—Cisplatin—urinary bladder cancer	0.000337	0.00123	CcSEcCtD
Gemfibrozil—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000333	0.00122	CcSEcCtD
Gemfibrozil—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000331	0.00121	CcSEcCtD
Gemfibrozil—Dizziness—Fluorouracil—urinary bladder cancer	0.000327	0.00119	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000327	0.00119	CcSEcCtD
Gemfibrozil—Diarrhoea—Cisplatin—urinary bladder cancer	0.000321	0.00117	CcSEcCtD
Gemfibrozil—Alopecia—Methotrexate—urinary bladder cancer	0.00032	0.00117	CcSEcCtD
Gemfibrozil—Vomiting—Gemcitabine—urinary bladder cancer	0.00032	0.00117	CcSEcCtD
Gemfibrozil—Mental disorder—Methotrexate—urinary bladder cancer	0.000317	0.00116	CcSEcCtD
Gemfibrozil—Rash—Gemcitabine—urinary bladder cancer	0.000317	0.00116	CcSEcCtD
Gemfibrozil—Dermatitis—Gemcitabine—urinary bladder cancer	0.000317	0.00116	CcSEcCtD
Gemfibrozil—Eye disorder—Epirubicin—urinary bladder cancer	0.000317	0.00116	CcSEcCtD
Gemfibrozil—Headache—Gemcitabine—urinary bladder cancer	0.000315	0.00115	CcSEcCtD
Gemfibrozil—Vomiting—Fluorouracil—urinary bladder cancer	0.000315	0.00115	CcSEcCtD
Gemfibrozil—Rhinitis—Doxorubicin—urinary bladder cancer	0.000315	0.00115	CcSEcCtD
Gemfibrozil—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000312	0.00114	CcSEcCtD
Gemfibrozil—Rash—Fluorouracil—urinary bladder cancer	0.000312	0.00114	CcSEcCtD
Gemfibrozil—Dermatitis—Fluorouracil—urinary bladder cancer	0.000312	0.00114	CcSEcCtD
Gemfibrozil—Headache—Fluorouracil—urinary bladder cancer	0.00031	0.00113	CcSEcCtD
Gemfibrozil—Dysgeusia—Methotrexate—urinary bladder cancer	0.000309	0.00113	CcSEcCtD
Gemfibrozil—Asthenia—Etoposide—urinary bladder cancer	0.000308	0.00113	CcSEcCtD
Gemfibrozil—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000308	0.00112	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000306	0.00112	CcSEcCtD
Gemfibrozil—Pruritus—Etoposide—urinary bladder cancer	0.000304	0.00111	CcSEcCtD
Gemfibrozil—Alopecia—Epirubicin—urinary bladder cancer	0.0003	0.00109	CcSEcCtD
Gemfibrozil—Nausea—Gemcitabine—urinary bladder cancer	0.000299	0.00109	CcSEcCtD
Gemfibrozil—Vomiting—Cisplatin—urinary bladder cancer	0.000298	0.00109	CcSEcCtD
Gemfibrozil—Vision blurred—Methotrexate—urinary bladder cancer	0.000297	0.00108	CcSEcCtD
Gemfibrozil—Mental disorder—Epirubicin—urinary bladder cancer	0.000297	0.00108	CcSEcCtD
Gemfibrozil—Rash—Cisplatin—urinary bladder cancer	0.000296	0.00108	CcSEcCtD
Gemfibrozil—Dermatitis—Cisplatin—urinary bladder cancer	0.000296	0.00108	CcSEcCtD
Gemfibrozil—Diarrhoea—Etoposide—urinary bladder cancer	0.000294	0.00107	CcSEcCtD
Gemfibrozil—Nausea—Fluorouracil—urinary bladder cancer	0.000294	0.00107	CcSEcCtD
Gemfibrozil—Eye disorder—Doxorubicin—urinary bladder cancer	0.000293	0.00107	CcSEcCtD
Gemfibrozil—Anaemia—Methotrexate—urinary bladder cancer	0.000292	0.00106	CcSEcCtD
Gemfibrozil—Flatulence—Epirubicin—urinary bladder cancer	0.000291	0.00106	CcSEcCtD
Gemfibrozil—Tension—Epirubicin—urinary bladder cancer	0.00029	0.00106	CcSEcCtD
Gemfibrozil—Dysgeusia—Epirubicin—urinary bladder cancer	0.000289	0.00105	CcSEcCtD
Gemfibrozil—Nervousness—Epirubicin—urinary bladder cancer	0.000287	0.00105	CcSEcCtD
Gemfibrozil—Dizziness—Etoposide—urinary bladder cancer	0.000284	0.00104	CcSEcCtD
Gemfibrozil—Vertigo—Methotrexate—urinary bladder cancer	0.000283	0.00103	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000283	0.00103	CcSEcCtD
Gemfibrozil—Leukopenia—Methotrexate—urinary bladder cancer	0.000282	0.00103	CcSEcCtD
Gemfibrozil—Nausea—Cisplatin—urinary bladder cancer	0.000279	0.00102	CcSEcCtD
Gemfibrozil—Vision blurred—Epirubicin—urinary bladder cancer	0.000278	0.00102	CcSEcCtD
Gemfibrozil—Alopecia—Doxorubicin—urinary bladder cancer	0.000277	0.00101	CcSEcCtD
Gemfibrozil—Cough—Methotrexate—urinary bladder cancer	0.000275	0.001	CcSEcCtD
Gemfibrozil—Mental disorder—Doxorubicin—urinary bladder cancer	0.000275	0.001	CcSEcCtD
Gemfibrozil—Convulsion—Methotrexate—urinary bladder cancer	0.000273	0.000997	CcSEcCtD
Gemfibrozil—Vomiting—Etoposide—urinary bladder cancer	0.000273	0.000997	CcSEcCtD
Gemfibrozil—Anaemia—Epirubicin—urinary bladder cancer	0.000273	0.000995	CcSEcCtD
Gemfibrozil—Rash—Etoposide—urinary bladder cancer	0.000271	0.000989	CcSEcCtD
Gemfibrozil—Dermatitis—Etoposide—urinary bladder cancer	0.000271	0.000988	CcSEcCtD
Gemfibrozil—Headache—Etoposide—urinary bladder cancer	0.000269	0.000982	CcSEcCtD
Gemfibrozil—Flatulence—Doxorubicin—urinary bladder cancer	0.000269	0.000982	CcSEcCtD
Gemfibrozil—Arthralgia—Methotrexate—urinary bladder cancer	0.000269	0.00098	CcSEcCtD
Gemfibrozil—Myalgia—Methotrexate—urinary bladder cancer	0.000269	0.00098	CcSEcCtD
Gemfibrozil—Chest pain—Methotrexate—urinary bladder cancer	0.000269	0.00098	CcSEcCtD
Gemfibrozil—Tension—Doxorubicin—urinary bladder cancer	0.000268	0.000978	CcSEcCtD
Gemfibrozil—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000267	0.000976	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000267	0.000973	CcSEcCtD
Gemfibrozil—Nervousness—Doxorubicin—urinary bladder cancer	0.000265	0.000968	CcSEcCtD
Gemfibrozil—Vertigo—Epirubicin—urinary bladder cancer	0.000265	0.000968	CcSEcCtD
Gemfibrozil—Syncope—Epirubicin—urinary bladder cancer	0.000265	0.000966	CcSEcCtD
Gemfibrozil—Leukopenia—Epirubicin—urinary bladder cancer	0.000264	0.000964	CcSEcCtD
Gemfibrozil—Confusional state—Methotrexate—urinary bladder cancer	0.00026	0.000947	CcSEcCtD
Gemfibrozil—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000259	0.000947	CcSEcCtD
Gemfibrozil—Cough—Epirubicin—urinary bladder cancer	0.000258	0.00094	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000257	0.000939	CcSEcCtD
Gemfibrozil—Vision blurred—Doxorubicin—urinary bladder cancer	0.000257	0.000939	CcSEcCtD
Gemfibrozil—Convulsion—Epirubicin—urinary bladder cancer	0.000256	0.000933	CcSEcCtD
Gemfibrozil—Nausea—Etoposide—urinary bladder cancer	0.000255	0.000931	CcSEcCtD
Gemfibrozil—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000252	0.000921	CcSEcCtD
Gemfibrozil—Anaemia—Doxorubicin—urinary bladder cancer	0.000252	0.000921	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000252	0.00092	CcSEcCtD
Gemfibrozil—Chest pain—Epirubicin—urinary bladder cancer	0.000251	0.000917	CcSEcCtD
Gemfibrozil—Myalgia—Epirubicin—urinary bladder cancer	0.000251	0.000917	CcSEcCtD
Gemfibrozil—Arthralgia—Epirubicin—urinary bladder cancer	0.000251	0.000917	CcSEcCtD
Gemfibrozil—Skin disorder—Methotrexate—urinary bladder cancer	0.00025	0.000912	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.00025	0.000911	CcSEcCtD
Gemfibrozil—Vertigo—Doxorubicin—urinary bladder cancer	0.000245	0.000895	CcSEcCtD
Gemfibrozil—Syncope—Doxorubicin—urinary bladder cancer	0.000245	0.000894	CcSEcCtD
Gemfibrozil—Leukopenia—Doxorubicin—urinary bladder cancer	0.000245	0.000892	CcSEcCtD
Gemfibrozil—Confusional state—Epirubicin—urinary bladder cancer	0.000243	0.000886	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000241	0.000879	CcSEcCtD
Gemfibrozil—Oedema—Epirubicin—urinary bladder cancer	0.000241	0.000879	CcSEcCtD
Gemfibrozil—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.00024	0.000876	CcSEcCtD
Gemfibrozil—Cough—Doxorubicin—urinary bladder cancer	0.000238	0.00087	CcSEcCtD
Gemfibrozil—Shock—Epirubicin—urinary bladder cancer	0.000237	0.000865	CcSEcCtD
Gemfibrozil—Convulsion—Doxorubicin—urinary bladder cancer	0.000237	0.000863	CcSEcCtD
Gemfibrozil—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000236	0.000862	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000236	0.000861	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000235	0.000856	CcSEcCtD
Gemfibrozil—Skin disorder—Epirubicin—urinary bladder cancer	0.000234	0.000854	CcSEcCtD
Gemfibrozil—Arthralgia—Doxorubicin—urinary bladder cancer	0.000233	0.000848	CcSEcCtD
Gemfibrozil—Chest pain—Doxorubicin—urinary bladder cancer	0.000233	0.000848	CcSEcCtD
Gemfibrozil—Myalgia—Doxorubicin—urinary bladder cancer	0.000233	0.000848	CcSEcCtD
Gemfibrozil—Paraesthesia—Methotrexate—urinary bladder cancer	0.000231	0.000843	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000231	0.000843	CcSEcCtD
Gemfibrozil—Somnolence—Methotrexate—urinary bladder cancer	0.000229	0.000835	CcSEcCtD
Gemfibrozil—Dyspepsia—Methotrexate—urinary bladder cancer	0.000227	0.000827	CcSEcCtD
Gemfibrozil—Confusional state—Doxorubicin—urinary bladder cancer	0.000225	0.00082	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000223	0.000813	CcSEcCtD
Gemfibrozil—Oedema—Doxorubicin—urinary bladder cancer	0.000223	0.000813	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000222	0.000811	CcSEcCtD
Gemfibrozil—Fatigue—Methotrexate—urinary bladder cancer	0.000222	0.00081	CcSEcCtD
Gemfibrozil—Pain—Methotrexate—urinary bladder cancer	0.00022	0.000803	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.00022	0.000801	CcSEcCtD
Gemfibrozil—Shock—Doxorubicin—urinary bladder cancer	0.000219	0.0008	CcSEcCtD
Gemfibrozil—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000219	0.000798	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000218	0.000796	CcSEcCtD
Gemfibrozil—Skin disorder—Doxorubicin—urinary bladder cancer	0.000217	0.00079	CcSEcCtD
Gemfibrozil—Paraesthesia—Epirubicin—urinary bladder cancer	0.000216	0.000789	CcSEcCtD
Gemfibrozil—Somnolence—Epirubicin—urinary bladder cancer	0.000214	0.000781	CcSEcCtD
Gemfibrozil—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000212	0.000774	CcSEcCtD
Gemfibrozil—Dyspepsia—Epirubicin—urinary bladder cancer	0.000212	0.000774	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000211	0.000768	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000208	0.000759	CcSEcCtD
Gemfibrozil—Fatigue—Epirubicin—urinary bladder cancer	0.000208	0.000758	CcSEcCtD
Gemfibrozil—Pain—Epirubicin—urinary bladder cancer	0.000206	0.000752	CcSEcCtD
Gemfibrozil—Constipation—Epirubicin—urinary bladder cancer	0.000206	0.000752	CcSEcCtD
Gemfibrozil—Urticaria—Methotrexate—urinary bladder cancer	0.000205	0.000746	CcSEcCtD
Gemfibrozil—Abdominal pain—Methotrexate—urinary bladder cancer	0.000204	0.000743	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000203	0.000741	CcSEcCtD
Gemfibrozil—Paraesthesia—Doxorubicin—urinary bladder cancer	0.0002	0.00073	CcSEcCtD
Gemfibrozil—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000199	0.000724	CcSEcCtD
Gemfibrozil—Somnolence—Doxorubicin—urinary bladder cancer	0.000198	0.000723	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000197	0.000719	CcSEcCtD
Gemfibrozil—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000196	0.000716	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000192	0.000702	CcSEcCtD
Gemfibrozil—Fatigue—Doxorubicin—urinary bladder cancer	0.000192	0.000701	CcSEcCtD
Gemfibrozil—Urticaria—Epirubicin—urinary bladder cancer	0.000191	0.000698	CcSEcCtD
Gemfibrozil—Constipation—Doxorubicin—urinary bladder cancer	0.000191	0.000696	CcSEcCtD
Gemfibrozil—Pain—Doxorubicin—urinary bladder cancer	0.000191	0.000696	CcSEcCtD
Gemfibrozil—Abdominal pain—Epirubicin—urinary bladder cancer	0.00019	0.000695	CcSEcCtD
Gemfibrozil—Asthenia—Methotrexate—urinary bladder cancer	0.000185	0.000674	CcSEcCtD
Gemfibrozil—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000184	0.00067	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000182	0.000665	CcSEcCtD
Gemfibrozil—Pruritus—Methotrexate—urinary bladder cancer	0.000182	0.000665	CcSEcCtD
Gemfibrozil—Urticaria—Doxorubicin—urinary bladder cancer	0.000177	0.000646	CcSEcCtD
Gemfibrozil—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000176	0.000643	CcSEcCtD
Gemfibrozil—Diarrhoea—Methotrexate—urinary bladder cancer	0.000176	0.000643	CcSEcCtD
Gemfibrozil—Asthenia—Epirubicin—urinary bladder cancer	0.000173	0.000631	CcSEcCtD
Gemfibrozil—Pruritus—Epirubicin—urinary bladder cancer	0.00017	0.000622	CcSEcCtD
Gemfibrozil—Dizziness—Methotrexate—urinary bladder cancer	0.00017	0.000621	CcSEcCtD
Gemfibrozil—Diarrhoea—Epirubicin—urinary bladder cancer	0.000165	0.000601	CcSEcCtD
Gemfibrozil—Vomiting—Methotrexate—urinary bladder cancer	0.000164	0.000597	CcSEcCtD
Gemfibrozil—Rash—Methotrexate—urinary bladder cancer	0.000162	0.000592	CcSEcCtD
Gemfibrozil—Dermatitis—Methotrexate—urinary bladder cancer	0.000162	0.000592	CcSEcCtD
Gemfibrozil—Headache—Methotrexate—urinary bladder cancer	0.000161	0.000588	CcSEcCtD
Gemfibrozil—Asthenia—Doxorubicin—urinary bladder cancer	0.00016	0.000584	CcSEcCtD
Gemfibrozil—Dizziness—Epirubicin—urinary bladder cancer	0.000159	0.000581	CcSEcCtD
Gemfibrozil—Pruritus—Doxorubicin—urinary bladder cancer	0.000158	0.000575	CcSEcCtD
Gemfibrozil—Vomiting—Epirubicin—urinary bladder cancer	0.000153	0.000559	CcSEcCtD
Gemfibrozil—Nausea—Methotrexate—urinary bladder cancer	0.000153	0.000558	CcSEcCtD
Gemfibrozil—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000153	0.000556	CcSEcCtD
Gemfibrozil—Rash—Epirubicin—urinary bladder cancer	0.000152	0.000554	CcSEcCtD
Gemfibrozil—Dermatitis—Epirubicin—urinary bladder cancer	0.000152	0.000554	CcSEcCtD
Gemfibrozil—Headache—Epirubicin—urinary bladder cancer	0.000151	0.000551	CcSEcCtD
Gemfibrozil—Dizziness—Doxorubicin—urinary bladder cancer	0.000147	0.000538	CcSEcCtD
Gemfibrozil—Nausea—Epirubicin—urinary bladder cancer	0.000143	0.000522	CcSEcCtD
Gemfibrozil—Vomiting—Doxorubicin—urinary bladder cancer	0.000142	0.000517	CcSEcCtD
Gemfibrozil—Rash—Doxorubicin—urinary bladder cancer	0.000141	0.000513	CcSEcCtD
Gemfibrozil—Dermatitis—Doxorubicin—urinary bladder cancer	0.00014	0.000512	CcSEcCtD
Gemfibrozil—Headache—Doxorubicin—urinary bladder cancer	0.00014	0.00051	CcSEcCtD
Gemfibrozil—Nausea—Doxorubicin—urinary bladder cancer	0.000132	0.000483	CcSEcCtD
Gemfibrozil—CYP2C9—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000128	0.000681	CbGpPWpGaD
Gemfibrozil—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	0.000127	0.000677	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—SLC19A1—urinary bladder cancer	0.000125	0.000667	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—HPGDS—urinary bladder cancer	0.000125	0.000666	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—ENO2—urinary bladder cancer	0.000125	0.000666	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	0.000124	0.000662	CbGpPWpGaD
Gemfibrozil—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	0.000123	0.000657	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PRSS3—urinary bladder cancer	0.000122	0.00065	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—GSTT1—urinary bladder cancer	0.000121	0.000646	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—RHOA—urinary bladder cancer	0.000121	0.000644	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	0.000119	0.000636	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	0.000119	0.000636	CbGpPWpGaD
Gemfibrozil—CYP2C9—Biological oxidations—GSTM1—urinary bladder cancer	0.000119	0.000635	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000119	0.000634	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000117	0.000626	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	0.000117	0.000622	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	0.000117	0.000622	CbGpPWpGaD
Gemfibrozil—PPARA—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000113	0.000604	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—ERBB2—urinary bladder cancer	0.000112	0.000596	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	0.000111	0.000593	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	0.000111	0.000593	CbGpPWpGaD
Gemfibrozil—CYP1A2—Biological oxidations—GSTP1—urinary bladder cancer	0.000111	0.00059	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	0.00011	0.000588	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000109	0.000582	CbGpPWpGaD
Gemfibrozil—CYP1A2—Biological oxidations—GSTM1—urinary bladder cancer	0.000102	0.000542	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—NQO1—urinary bladder cancer	0.000101	0.000536	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.0001	0.000535	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—NCOR1—urinary bladder cancer	9.91e-05	0.000529	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	9.77e-05	0.000521	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	9.76e-05	0.000521	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GSTZ1—urinary bladder cancer	9.74e-05	0.00052	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—TYMP—urinary bladder cancer	9.74e-05	0.00052	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—MMP9—urinary bladder cancer	9.58e-05	0.000511	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	9.37e-05	0.0005	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	9.35e-05	0.000499	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—ERCC2—urinary bladder cancer	9.32e-05	0.000497	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GSTO2—urinary bladder cancer	9.24e-05	0.000493	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—NAT1—urinary bladder cancer	9.24e-05	0.000493	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—EP300—urinary bladder cancer	9.09e-05	0.000485	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	9.08e-05	0.000485	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—SRC—urinary bladder cancer	8.84e-05	0.000471	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—NAT2—urinary bladder cancer	8.81e-05	0.00047	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GSTZ1—urinary bladder cancer	8.7e-05	0.000464	CbGpPWpGaD
Gemfibrozil—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	8.54e-05	0.000455	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	8.51e-05	0.000454	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—UGT2B7—urinary bladder cancer	8.45e-05	0.000451	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	8.42e-05	0.000449	CbGpPWpGaD
Gemfibrozil—PPARA—Generic Transcription Pathway—MYC—urinary bladder cancer	8.41e-05	0.000449	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—GSTP1—urinary bladder cancer	8.39e-05	0.000447	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GSTO2—urinary bladder cancer	8.24e-05	0.00044	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—NAT1—urinary bladder cancer	8.24e-05	0.00044	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	8.11e-05	0.000433	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	8.11e-05	0.000433	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GSTZ1—urinary bladder cancer	7.93e-05	0.000423	CbGpPWpGaD
Gemfibrozil—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	7.84e-05	0.000418	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—TYMS—urinary bladder cancer	7.8e-05	0.000416	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—ESR1—urinary bladder cancer	7.79e-05	0.000415	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—EGFR—urinary bladder cancer	7.74e-05	0.000413	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	7.74e-05	0.000413	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—NCOR1—urinary bladder cancer	7.71e-05	0.000411	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—GSTM1—urinary bladder cancer	7.71e-05	0.000411	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CYP4B1—urinary bladder cancer	7.61e-05	0.000406	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—RRM2—urinary bladder cancer	7.6e-05	0.000406	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—UGT2B7—urinary bladder cancer	7.54e-05	0.000402	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GSTO2—urinary bladder cancer	7.52e-05	0.000401	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—NAT1—urinary bladder cancer	7.52e-05	0.000401	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	7.39e-05	0.000394	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—GPX1—urinary bladder cancer	7.38e-05	0.000394	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—TNF—urinary bladder cancer	7.37e-05	0.000393	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—KRAS—urinary bladder cancer	7.32e-05	0.00039	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—ERCC2—urinary bladder cancer	7.25e-05	0.000387	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—SLC19A1—urinary bladder cancer	7.18e-05	0.000383	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—PPARG—urinary bladder cancer	7.1e-05	0.000379	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—HPGDS—urinary bladder cancer	7.04e-05	0.000376	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—ENO2—urinary bladder cancer	7.04e-05	0.000376	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PRSS3—urinary bladder cancer	7e-05	0.000373	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	7e-05	0.000373	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	6.87e-05	0.000367	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—GSTT1—urinary bladder cancer	6.83e-05	0.000364	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—CREBBP—urinary bladder cancer	6.82e-05	0.000364	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—MTHFR—urinary bladder cancer	6.81e-05	0.000363	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CYP4B1—urinary bladder cancer	6.79e-05	0.000362	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	6.78e-05	0.000361	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	6.72e-05	0.000359	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	6.42e-05	0.000343	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—NAT1—urinary bladder cancer	6.42e-05	0.000343	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	6.41e-05	0.000342	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	6.39e-05	0.000341	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	6.32e-05	0.000337	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	6.25e-05	0.000333	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—HRAS—urinary bladder cancer	6.22e-05	0.000332	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	6.19e-05	0.00033	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	5.87e-05	0.000313	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	5.85e-05	0.000312	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	5.7e-05	0.000304	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—NQO1—urinary bladder cancer	5.67e-05	0.000303	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	5.61e-05	0.000299	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—TYMP—urinary bladder cancer	5.6e-05	0.000299	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—PPARG—urinary bladder cancer	5.52e-05	0.000295	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	5.51e-05	0.000294	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	5.37e-05	0.000287	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—CREBBP—urinary bladder cancer	5.31e-05	0.000283	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	5.29e-05	0.000282	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	5.23e-05	0.000279	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—NAT2—urinary bladder cancer	5.06e-05	0.00027	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	5.01e-05	0.000267	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	5e-05	0.000266	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—TYMP—urinary bladder cancer	4.99e-05	0.000266	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	4.96e-05	0.000264	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—NAT1—urinary bladder cancer	4.96e-05	0.000264	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	4.87e-05	0.00026	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	4.8e-05	0.000256	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	4.8e-05	0.000256	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—GSTP1—urinary bladder cancer	4.73e-05	0.000253	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	4.58e-05	0.000244	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	4.57e-05	0.000244	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—TYMP—urinary bladder cancer	4.55e-05	0.000243	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	4.53e-05	0.000242	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—NAT2—urinary bladder cancer	4.52e-05	0.000241	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—TYMS—urinary bladder cancer	4.4e-05	0.000235	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	4.37e-05	0.000233	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—RRM2—urinary bladder cancer	4.37e-05	0.000233	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—NCOR1—urinary bladder cancer	4.35e-05	0.000232	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—GSTM1—urinary bladder cancer	4.35e-05	0.000232	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—PTGS2—urinary bladder cancer	4.34e-05	0.000232	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—GPX1—urinary bladder cancer	4.17e-05	0.000222	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—NAT2—urinary bladder cancer	4.12e-05	0.00022	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—ERCC2—urinary bladder cancer	4.09e-05	0.000218	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	4.08e-05	0.000218	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—MYC—urinary bladder cancer	4.05e-05	0.000216	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—ENO2—urinary bladder cancer	4.05e-05	0.000216	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	4.05e-05	0.000216	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	4.02e-05	0.000215	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	3.92e-05	0.000209	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.9e-05	0.000208	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—RRM2—urinary bladder cancer	3.9e-05	0.000208	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—TYMP—urinary bladder cancer	3.89e-05	0.000208	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.86e-05	0.000206	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	3.86e-05	0.000206	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—MTHFR—urinary bladder cancer	3.84e-05	0.000205	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—PTEN—urinary bladder cancer	3.79e-05	0.000202	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	3.76e-05	0.0002	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.74e-05	0.000199	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—EP300—urinary bladder cancer	3.61e-05	0.000193	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	3.61e-05	0.000193	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—ENO2—urinary bladder cancer	3.61e-05	0.000193	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.59e-05	0.000192	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—RRM2—urinary bladder cancer	3.56e-05	0.00019	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—NAT2—urinary bladder cancer	3.52e-05	0.000188	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	3.5e-05	0.000187	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.45e-05	0.000184	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ENO2—urinary bladder cancer	3.29e-05	0.000176	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	3.29e-05	0.000176	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.27e-05	0.000175	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—NQO1—urinary bladder cancer	3.26e-05	0.000174	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	3.19e-05	0.00017	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.16e-05	0.000169	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.14e-05	0.000168	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PPARG—urinary bladder cancer	3.12e-05	0.000166	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—RRM2—urinary bladder cancer	3.04e-05	0.000162	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—TYMP—urinary bladder cancer	3e-05	0.00016	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—CREBBP—urinary bladder cancer	2.99e-05	0.00016	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—NQO1—urinary bladder cancer	2.91e-05	0.000155	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.82e-05	0.000151	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	2.81e-05	0.00015	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ENO2—urinary bladder cancer	2.81e-05	0.00015	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.8e-05	0.000149	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.76e-05	0.000147	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	2.73e-05	0.000146	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	2.72e-05	0.000145	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—NAT2—urinary bladder cancer	2.72e-05	0.000145	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.69e-05	0.000143	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—NQO1—urinary bladder cancer	2.65e-05	0.000142	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.63e-05	0.00014	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.57e-05	0.000137	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—TYMS—urinary bladder cancer	2.53e-05	0.000135	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	2.5e-05	0.000133	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	2.5e-05	0.000133	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.46e-05	0.000131	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PTGS2—urinary bladder cancer	2.45e-05	0.000131	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	2.43e-05	0.00013	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GPX1—urinary bladder cancer	2.39e-05	0.000128	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	2.35e-05	0.000125	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.35e-05	0.000125	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—RRM2—urinary bladder cancer	2.34e-05	0.000125	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—NQO1—urinary bladder cancer	2.27e-05	0.000121	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—TYMS—urinary bladder cancer	2.26e-05	0.00012	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.25e-05	0.00012	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	2.23e-05	0.000119	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	2.23e-05	0.000119	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	2.21e-05	0.000118	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	2.21e-05	0.000118	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.2e-05	0.000117	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ENO2—urinary bladder cancer	2.17e-05	0.000116	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	2.17e-05	0.000116	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.14e-05	0.000114	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PTEN—urinary bladder cancer	2.14e-05	0.000114	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GPX1—urinary bladder cancer	2.14e-05	0.000114	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	2.11e-05	0.000112	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	2.1e-05	0.000112	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—TYMS—urinary bladder cancer	2.06e-05	0.00011	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—EP300—urinary bladder cancer	2.04e-05	0.000109	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	2.03e-05	0.000109	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	2.03e-05	0.000109	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	1.97e-05	0.000105	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GPX1—urinary bladder cancer	1.95e-05	0.000104	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.92e-05	0.000102	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	1.91e-05	0.000102	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	1.89e-05	0.000101	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.83e-05	9.76e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	1.8e-05	9.59e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PPARG—urinary bladder cancer	1.79e-05	9.56e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—TYMS—urinary bladder cancer	1.76e-05	9.38e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.75e-05	9.34e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	1.74e-05	9.27e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	1.74e-05	9.27e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	1.72e-05	9.18e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GPX1—urinary bladder cancer	1.66e-05	8.88e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	1.63e-05	8.72e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PPARG—urinary bladder cancer	1.6e-05	8.53e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	1.54e-05	8.2e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	1.54e-05	8.19e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.46e-05	7.79e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PPARG—urinary bladder cancer	1.46e-05	7.78e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	1.41e-05	7.52e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	1.4e-05	7.47e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.36e-05	7.24e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.34e-05	7.16e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.34e-05	7.16e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.28e-05	6.85e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.26e-05	6.73e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	1.26e-05	6.71e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PPARG—urinary bladder cancer	1.25e-05	6.65e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PTEN—urinary bladder cancer	1.23e-05	6.56e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	1.2e-05	6.38e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.19e-05	6.33e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—EP300—urinary bladder cancer	1.17e-05	6.25e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	1.15e-05	6.12e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PTEN—urinary bladder cancer	1.1e-05	5.85e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—EP300—urinary bladder cancer	1.05e-05	5.58e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PTEN—urinary bladder cancer	1e-05	5.34e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	9.8e-06	5.23e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PPARG—urinary bladder cancer	9.61e-06	5.13e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—EP300—urinary bladder cancer	9.54e-06	5.09e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	9.24e-06	4.93e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PTEN—urinary bladder cancer	8.55e-06	4.56e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—EP300—urinary bladder cancer	8.15e-06	4.35e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	7.56e-06	4.03e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PTEN—urinary bladder cancer	6.6e-06	3.52e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—EP300—urinary bladder cancer	6.29e-06	3.36e-05	CbGpPWpGaD
